Maxcyte Share Discussion Threads

[apad] 31/8/2021 08:54

I've given up trying to find a short term relationship between NASDAQ and AIM prices. 😊. There must be a longterm relationship.

With the recent offering and listing I'm assuming that all the good news has been polished and displayed, so I am not expecting much new from the Sept. interims, however they might be able to be used to generate interest in the US.

I think it makes most sense to watch the newsflow in the lead up to April FY.

Keep the quality of the posts up here please folks.

apad

[nimbo1] 31/8/2021 08:12

Trident thats your opinion and market doesn't care for individual opinions. If you had listened to the market you could have made decent profits here - hope you did otherwise you've been wasting your time posting here.

[tictac] 30/8/2021 19:46

The early market spike is just a badly handled buy order. The broker concerned may just be in a little bit of trouble with his client. Nonetheless, "buy on open" orders (which it looks like this was) can't be a bad thing.

We'll see.

[trident5] 30/8/2021 19:36

Let's hope it can get revenue up to a tenth of that and make more profit than I get paid. It's a valuation factoring in a lot of good news to come, no bad news and no market downturn.

[multibagger] 30/8/2021 19:08

Many thanks nimbo1 !

Quoting about $16 now - around £11.65 if this holds....expecting a good day for MXCT tomorrow :)

[nimbo1] 30/8/2021 17:30

Funny to think back probably less than a year when trident tried to mock me when I suggested maxcyte could be a billion pound co.

[nimbo1] 30/8/2021 17:21

US price equivalent to about £11.80 currently. So could be back to 11.50 tomorrow with a gap up if things stay the same.

[assagai] 30/8/2021 16:18

Look again

[trident5] 30/8/2021 14:45

It's showing up 1 cent.

[thetrotsky] 30/8/2021 11:13

I see that the pre-market quote on NASDAQ is currently USD16.80, up USD1 on Friday's close; looking promising

[thetrotsky] 30/8/2021 11:05

With a range of USD18-36, there could be some furtehr intersting action on NASDAQ today; fingers crossed

[thetrotsky] 30/8/2021 11:03

I like USD36 ;-)

[acuere] 29/8/2021 18:47

Here is a summary of the broker ratings that appeared on 24th Aug.

William Blair Outperform
Stephens & Co. Overweight USD 19
BTIG Research Buy USD 22
Stifel Nicolaus Buy USD 18
Cowen Outperform
Wedbush Outperform USD 36.

[thetrotsky] 28/8/2021 08:19

Closed up over 12% in the US overnight at $15.80 (equivalent to ~£11.45). It will be interesting to see what the share price does on Monday (not a bank holiday in the US).

[charliec51] 25/8/2021 12:44

Thank you Pob, very useful. I also like this from the same note - lock in with clients is a big plus imv:

"Since MaxCyte’s technology is formally included in regulatory filings, we see little risk of SPL customers moving away from the company after entering the clinic."

[pob69] 25/8/2021 07:27

More from broker William Blair

"...make investing in the company a one-of-a-kind opportunity in life sciences"

[pob69] 24/8/2021 10:14

Seems like lots of new broker coverage detailed on twitter (sources not verified)

2 brokers involved in the US IPO
MaxCyte initiated with an Outperform at Cowen (TP not mentioned)
Maxcyte Initiation (Stifel) with a $18 TP

Addiytionally
BTIG analyst Mark Massaro initiates coverage on MaxCyte Inc. (NASDAQ: MXCT) with a Buy rating and a price target of $22.00.

[pob69] 13/8/2021 07:39

Partner Allogene updates market on ALLO-715

[multibagger] 11/8/2021 10:51

Thanks for sharing pob69 !

Interestingly the same Richard Penny /Crux Asset Management holds 3.11% of CYAN having taken part in the recent funding round.

DoI: CYAN is another of my big investments.

[pob69] 11/8/2021 10:43

Interesting comment from Richard Penny of Crux Asset Management in the telegraph (behind paywall)

"...I understand that MaxCyte is very happy that there is a strong balance between the existing specialist healthcare investors and some newer institutions. We retain a position in the stock. I would expect the company to accelerate growth and make incremental acquisitions with the proceeds. There is a positive outlook for the next 18 months."

[thetrotsky] 10/8/2021 15:28

There does appear to be an arbitrage opportunity between the UK and US markets at the moment. I wouldn't be too surprised to see the US market start to recover after the UK market closes. We may even see the US share price retesting the previous day's close. Just a hunch.

[nimbo1] 10/8/2021 10:30

From memory I think they more as part of nasdaq ipo if one reads the small print

[apad] 10/8/2021 09:40

Interesting grant of options today.

Looks fair(ish).

apad

[trident5] 10/8/2021 07:48

Does that mean the Yanks are not in for the long run?